title: Pre- and intraoperative mitomycin C for recurrent pterygium associated with symblepharon.
abstract: BACKGROUND
  Treatment of recurrent pterygium associated with symblepharon usually involves the use of tissue grafting and/or the intraoperative application of mitomycin C (MMC). For the graft, a conjunctival/limbal autograft and/or amniotic membrane may be used. This generally requires extra technical skills and assistance, an increase in the cost and duration of surgery, and a more extensive anesthesia (a complete eye block or general anesthesia). Although widely used, safety concerns have been raised over MMC in the treatment of pterygia.
  
  
  OBJECTIVE
  The objective of this case report is to report the successful use of preoperative subconjunctival injection of low-dose (0.02%) MMC one month before bare sclera excision of a multirecurrent pterygium, as well as the concomitant intraoperative application of MMC to the conjunctival fornix of the same eye after the excision of an associated symblepharon.
  
  
  METHODS
  A 31-year-old man from Kano, Northern Nigeria, presented to the eye clinic with a recurrent pterygium associated with an upper lid symblepharon in his right eye. He has had five previous pterygium excisions, with the last surgery involving conjunctival autografting and subconjunctival steroid injection. He was subsequently given 0.1 mL of 0.02% MMC as a subpterygial injection; one month later he had an alcohol-assisted bare sclera pterygium excision and a symblepharolysis with the intraoperative application of 0.02% MMC for 1 minute to the upper conjunctival fornix. Except for a Tenon granuloma that was simply excised, there has been no recurrence or other complications up to a year after surgery.
  
  
  CONCLUSIONS
  As a cheaper and technically easier treatment option, a preoperative subconjunctival MMC injection followed by bare sclera pterygium excision was found to be effective in this patient with a recurrent pterygium. As at one-year follow-up, low-dose preoperative MMC a month prior to surgery also appeared safe and effective when combined with its intraoperative application to the conjunctival fornix for the treatment of associated symblepharon.
authors: Department of Ophthalmology, Aminu Kano Teaching Hospital, Kano, Nigeria.
authors: Isyaku
authors: I
authors: Mohammed
keywords: mitomycin C; pterygium; recurrence; symblepharon
references: Curr Opin Ophthalmol. 2007 Jul;18(4):308-13
references: 17568207
references: Int J Mol Med. 2009 Apr;23(4):439-47
references: 19288018
references: Ann Afr Med. 2011 Jul-Sep;10(3):197-203
references: 21912002
references: Arch Ophthalmol. 2002 Nov;120(11):1585-6
references: 12427079
references: Am J Ophthalmol. 2011 Nov;152(5):730-2
references: 21742307
references: Ophthalmology. 2009 Jul;116(7):1278-86
references: 19576496
references: Br J Ophthalmol. 1998 Mar;82(3):235-40
references: 9602618
references: Ophthalmology. 2003 May;110(5):1012-6
references: 12750105
references: Orbit. 2007 Mar;26(1):5-13
references: 17510864
references: Ophthalmology. 1992 Nov;99(11):1647-54
references: 1454338
references: Indian J Ophthalmol. 2012 Jul;60(4):273-6
references: 22824595
references: Br J Ophthalmol. 2002 Mar;86(3):357-8
references: 11864903
references: Cornea. 2001 Jan;20(1):24-9
references: 11188998